Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-01-18, Stock:LLY, The news for the past five days is as follows:
2018-01-10: NEWS1: Eli Lilly & Co. at J.P. Morgan: 5 Things Investors Will Want to Know.NEWS2: Eli Lilly & Co. at J.P. Morgan: 5 Things Investors Will Want to Know.
2018-01-11: NEWS1: Elanco Announces Addition of New North America and Global Strategy Senior Executive.NEWS2: Big Pharma CEOs Speak About Impact of Tax Reform on M&A.NEWS3: How Mylan’s Rest of the World Segment Performed in 3Q17.NEWS4: Elanco, Aratana Announce Marketing Authorization of GALLIPRANT® (grapiprant tablets) in Europe.
2018-01-12: NEWS1: Three Diabetes Clinical Trials to Watch in 2018.NEWS2: Merck's Keytruda on a Roll: Can it Retain the Spark in 2018?.NEWS3: Lilly's Elanco/Aratana's Veterinary Medicine Gets EU Nod.NEWS4: Dow 30 Stock Roundup: Boeing Q4 Deliveries Up Y/Y, Success for Merck's Keytruda Combo.NEWS5: Lilly&apos;s Elanco/Aratana&apos;s Veterinary Medicine Gets EU Nod.NEWS6: Wall Street Recommendations for Mylan in January 2018.
2018-01-16: NEWS1: How This Biotech Stock Could Top Bigger Rivals In Preventing Migraines.NEWS2: How This Biotech Stock Could Top Bigger Rivals In Preventing Migraines.NEWS3: 3 Top Healthcare Stocks to Buy Right Now.NEWS4: Eli Lilly's Risks Could Be Underappreciated, Goldman Sachs Says In Downgrade.NEWS5: Big Pharma: Merck Zooms, Eli Lilly Lags.
2018-01-17: NEWS1: U.S. Senate committee advances Azar nomination as health secretary.NEWS2: Key U.S. Senate committee advances Azar nomination for HHS secretary.NEWS3: Merck Strong on Confirmatory Phase III Lung Cancer Study.NEWS4: Nektar Boasts Strong Pipeline, Competition Remains a Woe.NEWS5: A Rally in Eli Lilly Could Heal Traders, Investors.NEWS6: Is Eli Lilly and Company a Buy in 2018?.NEWS7: Is Eli Lilly and Company a Buy in 2018?.NEWS8: Teva Pharmaceutical: Still Focused on New Product Launches.

Answer: Decrease